SCHEMBL31306259

SCHEMBL31306259

CCOC(=O)Cn1ccc2cc(Cl)ccc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 7/20 0.51
▸ ALDH1A1 P00352 5/20 0.48
▸ HTT P42858 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ USP2 O75604 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ LMNA P02545 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20786879 0.85 TNF (0.51) TNFALDH1A1MEN1KMT2AHPGD
SCHEMBL20037218 0.83 TDP1 (0.53) ALDH1A1HTTMAPTMEN1KMT2A
SCHEMBL31306252 0.81 ITGB3 (0.51) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL5143014 0.80 KMO (0.55) ALDH1A1HTTMAPTHSD17B10MEN1
SCHEMBL29958540 0.80 KMO (0.55) ALDH1A1HTTMAPTHSD17B10MEN1
SCHEMBL31743124 0.79 DDR1 (0.44) TNFALDH1A1MAPTMEN1KMT2A
SCHEMBL18955878 0.77 PSMB1 (0.58) TNFALDH1A1MEN1KMT2AKDM4E
SCHEMBL22404777 0.77 PSMB1 (0.47) TNFALDH1A1MEN1KMT2AUSP2
SCHEMBL30711650 0.76 KMO (0.56) ALDH1A1HTTHSD17B10MEN1KMT2A
SCHEMBL29174301 0.76 KMO (0.56) ALDH1A1HTTHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734979-A2 TMEM175 AGONISTS, COMPOSITIONS, AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2026-05-06 — — EP disclosed
WO-2025006723-A2 TMEM175 AGONISTS, COMPOSITIONS, AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2025-01-02 — — WO disclosed
Send feedback